Abstracts Archive - Page 1077 of 2607 - ACR Meeting Abstracts

Abstract Number: 2054 • 2019 ACR/ARP Annual Meeting
Epidemiology of Gout in South Korea with the National Health Insurance Corporation Database
Jinsu Park¹, Jung-Soo Song ², Minjin Kang ³ and Chan Hee Lee ⁴, ¹Division of Rheumatology, Department of International Medicine, National Health Insurance Service Ilsan hospital, Goyang-si, Republic of Korea, ²Chung-Ang University College of Medicine, Seoul, Republic of Korea, ³Research and analysis Team, NHIS Ilsan hospital, Goyang-si, Republic of Korea, ⁴Division of Rheumatology, Department of Internal Medicine, National Health Insurance Service Ilsan Hospital, Goyang, Republic of Korea
Background/Purpose: Gout is the most common inflammatory arthritis that results from chronic elevation of uric acid levels above the saturation point for monosodium urate crystal…
Abstract Number: 2055 • 2019 ACR/ARP Annual Meeting
High Dietary Sodium Intake May Be Associated with Symptomatic Knee Osteoarthritis in a Korean Population: Korean National Health and Nutrition Examination Survey, 2010-2011
You-Jung Ha¹, Eunjeong Ji ², Eun Hye Park ¹, Eun Ha Kang ¹, Yeong-Wook Song ³ and Yun Jong Lee ⁴, ¹Division of Rheumatology, Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Republic of Korea, Seongnam, Republic of Korea, ²Medical Research Collaborating Center (MRCC), Seoul National University Bundang Hospital, Seongnam, Republic of Korea, ³Seoul National University Hospital, Seoul, Republic of Korea, ⁴Division of Rheumatology, Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Republic of Korea
Background/Purpose: A high sodium intake has been reported to adversely affect bone health and to be associated with an increased inflammatory response. However, the relationship…
Abstract Number: 2056 • 2019 ACR/ARP Annual Meeting
Opioids Use Among Medicare Beneficiaries with Knee Osteoarthritis: Prevalence and Correlates of Chronic Use
Elena Losina¹, Shuang Song ² and Jeffrey Katz ³, ¹Brigham and Women's Hospital and Harvard Medical School, Boston, MA, ²Brigham and Women's Hospital, Boston, MA, ³Brigham and Women's Hospital/Harvard Medical School, Boston
Background/Purpose: Osteoarthritis (OA) of the knee is prevalent among Medicare beneficiaries. Effective pain control is critical for managing this chronic disease. In the last decade,…
Abstract Number: 2057 • 2019 ACR/ARP Annual Meeting
Cross-sectional Associations of Multiple Joint Osteoarthritis in the Osteoarthritis Initiative
Charles Eaton¹, Mary Roberts ², Jeffrey Driban ³, Michael Nevitt ⁴, Jeffrey Duryea ⁵ and Timothy McAlindon ⁶, ¹Warren Alpert Medical School of Brown University, Pawtucket, RI, ²Center for Primary Care and Prevention, Pawtucket, ³Tufts Medical Center, Boston, ⁴University of California at San Francisco, San Francisco, CA, ⁵Harvard Medical School Department of Radiology Brigham and Women's Hospital, Boston, MA, ⁶Tufts Medical Center, Boston, MA
Background/Purpose: Multiple joint osteoarthritis (MJOA) may represent a unique phenotype of osteoarthritis related to systemic factors associated with pathologic aging. We tested the hypothesis that metabolic…
Abstract Number: 2058 • 2019 ACR/ARP Annual Meeting
Pharmacoepidemiology of Gout Treatment in Office-based Outpatient Care from 2009- 2016
Yu Pei Chock¹, Joseph Ross ¹, Lisa Suter ² and Taeho Greg Rhee ¹, ¹Yale School of Medicine, New Haven, ²Yale University/VA CT Healthcare System, New Haven
Background/Purpose: Studies show that gout treatment remains suboptimal in the United States (US). Despite clear benefits for urate-lowering therapy (ULT) for chronic gout, surveyed physicians…
Abstract Number: 2059 • 2019 ACR/ARP Annual Meeting
Usage of Predicting Out-of-Office Blood Pressure Calculator in Hispanic Patients with Rheumatic Diseases
Dionicio Galarza-Delgado ¹, Jose Azpiri-Lopez ¹, Iris Colunga-Pedraza ¹, Carolina Marlene Martinez-Flores¹, Marielva Castro-Gonzalez ¹, Ileana Cecilia Reynosa-Silva ¹, Karla Paola Cuellar-Calderon ¹ and Raymundo Vera-Pineda ², ¹Universidad Autonoma de Nuevo Leon, Hospital Universitario "Dr Jose Eleuterio Gonzalez", Monterrey, Nuevo Leon, Mexico, ²Universidad Autonoma de Nuevo Leon, Hospital Universitario "Dr. Jose Eleuterio Gonzalez", Monterrey, Nuevo Leon, Mexico
Background/Purpose: Subjects with rheumatic diseases have an increased risk of cardiovascular (CV) morbimortality. Hypertension (HTN) is a key modifiable risk factor for CV events. A…
Abstract Number: 2060 • 2019 ACR/ARP Annual Meeting
The Current State of Big Data Use and Artificial Intelligence in RMDs: A Systematic Literature Review Informing EULAR Recommendations
Joanna Kedra¹, Timothy R.D. Radstake ², Aridaman Pandit ³, Xenofon Baraliakos ⁴, Francis Berenbaum ⁵, Axel Finckh ⁶, Bruno Fautrel ⁷, Tanja Stamm ⁸, David Gomez-Cabrero ⁹, Christian Pristipino ¹⁰, Remy Choquet ¹¹, Hervé Servy ¹², Simon Stones ¹³, Gerd Burmester ¹⁴ and Laure Gossec ¹⁵, ¹Sorbonne Université, Institut Pierre Louis d'Epidémiologie et de Santé Publique (iPLESP), UMR S1136, Paris France, Paris, France, ²Department of Rheumatology/Clinical Immunology, University Medical Center Utrecht, Utrecht, The Netherlands., Utrecht, Netherlands, ³Dept. of Rheumatology, Clinical Immunology and Laboratory for Translational Immunology, University Medical Center Utrecht, The Netherlands, Utrecht, Netherlands, ⁴Rheumazentrum Ruhrgebiet-Ruhr-University Bochum, Herne, Germany, Herne, Germany, ⁵Sorbonne Université-Inserm CDR Saint-Antoine, AP-HP, Paris, France, ⁶Division of Rheumatology, Geneva University Hospital, Switzerland, Geneva, Switzerland, ⁷Pitié-Salpêtrière Hospital, Department of Rheumatology, AP-HP, Sorbonne University, UPMC university, Paris, Ile-de-France, France, ⁸Medical University of Vienna, Vienna, Austria, ⁹Translational Bioinformatics Unit, Navarra Biomed, Departamento de Salud-Universidad Pública de Navarra, Pamplona, Navarra, Spain, Pamplona, Spain, ¹⁰Ospedale San Filippo Neri, Rome, Italy., Rome, Italy, ¹¹INSERM U1142, Orange Healthcare, France, Paris, France, ¹²Sanoia e-health services, France, Paris, France, ¹³School of Healthcare, University of Leeds, Leeds, UK, Leeds, United Kingdom, ¹⁴Charité—University Medicine Berlin, Berlin, Germany, ¹⁵Sorbonne Université and Hôpital Pitié-Salpêtrière, Paris, France
Background/Purpose: Big data are defined as data sets that are too large or complex for traditional data-processing application software to adequately deal with. Artificial Intelligence…
Abstract Number: 2061 • 2019 ACR/ARP Annual Meeting
Association of Periodontitis with Rheumatological Disorders: NHANES III Analysis
Vivekanand Tiwari¹, Lawrence Brent ¹, Jasim Albandar ², Chinhua Hsiao ² and Shikha Shah ³, ¹Temple University, Philadelphia, PA, ²Kornberg School of Dentistry, Temple University, Philadelphia, PA, ³Levy Center for Oral Health Research, Philadelphia, PA
Background/Purpose: The association between periodontal diseases, smoking, and some systemic diseases such as diabetes mellitusis is well established. Periodontitis and rheumatological disorders share common immunological features and…
Abstract Number: 2062 • 2019 ACR/ARP Annual Meeting
Arthritis, Physical Function, and Disability Among Older Mexican Americans over 20-Years of Follow-up
Martin A Rodriguez¹, Lin-Na Chou ¹, Jaspreet K Sodhi ¹, Kyriakos S Markides ¹, Kenneth J Ottenbacher ¹ and Soham Al Snih ¹, ¹The University of Texas Medical Branch, Galveston
Background/Purpose: Hispanics are the fastest growing group of older adults in the US, with older Mexican Americans the largest segment of US Hispanics (65%), a…
Abstract Number: 2063 • 2019 ACR/ARP Annual Meeting
Arthritis, Upper-Lower Extremity Functional Limitations, and Disability in American Older Adults: Findings from the National Health and Aging Trends Study (NHATS)
Martin A Rodriguez¹, Jaspreet K Sodhi ¹ and Soham Al Snih ¹, ¹The University of Texas Medical Branch, Galveston
Background/Purpose: To examine the effect of arthritis on upper-lower extremity (UE-LE) functional limitations and disability over 6-years of follow-up among American older adults.Methods: Data are…
Abstract Number: 2064 • 2019 ACR/ARP Annual Meeting
Evaluation of Methods to Account for Differential Follow-up When Comparing Clinical Trial Data to Observational Data
Vibeke Norvang¹, Espen Haavardsholm ¹, Sara K. Tedeschi ², Houchen Lyu ³, Tore Kvien ¹, Maria Dahl Mjaavatten ⁴, Daniel Solomon ⁵ and Kazuki Yoshida ⁶, ¹Diakonhjemmet Hospital, Dept. of Rheumatology / University of Oslo, Faculty of Medicine, Oslo, Norway, ²Brigham and Women's Hospital, Div. of Rheumatology, Immunology and Allergy, Boston, MA, ³Brigham and Women´s Hospital, Div. of Rheumatology, Immunology and Allergy, Boston, ⁴Diakonhjemmet Hospital, Dept. of Rheumatology, Oslo, Norway, ⁵Brigham and Women´s Hospital, Div. of Rheumatology, Immunology and Allergy, Boston, MA, ⁶Brigham and Women's Hospital, Div. of Rheumatology, Immunology and Allergy, Boston
Background/Purpose: Comparing the outcomes of an intervention in a clinical trial versus an observational study might help identify challenges in translating results from clinical trials…
Abstract Number: 2065 • 2019 ACR/ARP Annual Meeting
Association Between Anemia and Hyperuricemia: Korean National Health and Nutrition Survey 2016-2017
Seulkee Lee¹, Yeonghee Eun ¹, Jiwon Hwang ², Hoon-Suk Cha ¹, Eun-Mi Koh ¹, Jaejoon Lee ¹ and Hyungjin Kim ¹, ¹Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea, ²Samsung Changwon Hospital, Sungkyunkwan University School of Medicine, Changwon, Republic of Korea
Background/Purpose: Hyperuricemia and anemia may be related in terms of sharing comorbidities such as chronic kidney disease (CKD) and cardiovascular disease. However, to our knowledge,…
Abstract Number: 2066 • 2019 ACR/ARP Annual Meeting
Clinical, Serologic and Morphologic Features of Interstitial Pneumonia with Autoimmune Features (IPAF): A Single Center Experience
Michael Allen¹, Emily Press ¹, Aditi Mathur ¹, Sakshi Dua ², Maria Padilla ² and Ioannis Tassiulas ², ¹Icahn School of Medicine at Mt Sinai, New York, ²Icahn School of Medicine, New York
Background/Purpose: Interstitial lung disease (ILD) encompasses a group of disorders that are classified together based on similar clinical, radiographic and pathologic findings. ILD is highly…
Abstract Number: 2067 • 2019 ACR/ARP Annual Meeting
Comparison of Medication New User Definitions in Multi-Specialty EMR Data
Jeffrey Curtis¹, Lang Chen ¹, Narender Annapureddy ², Cassie Clinton ¹, Megan Clowse ³, Millie Long ⁴, W. Benjamin Nowell ⁵, Jim Oates ⁶, Rennie Rhee ⁷, Siddarth Singh ⁸, Fenglong Xie ⁹ and Timothy Beukelman ¹⁰, ¹University of Alabama at Birmingham, Birmingham, AL, ²Vanderbilt University, Nashville, TN, ³Duke University, Durham, ⁴University of North Carolina Chapel Hill, Chapel Hill, NC, ⁵Global Healthy Living Foundation, Upper Nyack, NY, ⁶Division of Rheumatology & Immunology/Medical University of South Carolina, Charleston, SC, ⁷University of Pennsylvania, Division of Rheumatology, Philadelphia, PA, ⁸University California, San Diego, San Diego, ⁹University of Alabama at Birmingham, Birmingham, ¹⁰University of Alabama Birmingham, Birmingham, AL
Background/Purpose: New user designs are typically preferred in pharmacoepidemiology to avoid bias. The optimal implementation of a new user design in electronic medical record (EMR)…
Abstract Number: 2068 • 2019 ACR/ARP Annual Meeting
Body Mass Index and Systemic Corticosteroid Use as Indicators of Disease Burden and Their Influence on the Safety Profile of Certolizumab Pegol Across Indications
Vivian Bykerk¹, Andrew Blauvelt ², Jeffrey Curtis ³, Cécile Gaujoux-Viala ⁴, Tore K. Kvien ⁵, William J. Sandborn ⁶, Kevin Winthrop ⁷, Christina Popova ⁸ and Xavier Mariette ⁹, ¹Hospital for Special Surgery, New York City, NY, ²Oregon Medical Research Center, Portland, OR, USA, Portland, OR, ³University of Alabama at Birmingham, Birmingham, AL, ⁴Nîmes University Hospital, Nîmes, France, ⁵Diakonhjemmet Hospital, Oslo, Norway, ⁶University of California, La Jolla, CA, ⁷Oregon Health and Science University, Portland, OR, ⁸UCB Pharma, Brussels, Belgium, ⁹Center for Immunology of Viral Infections and Autoimmune Diseases, Assistance Publique – Hôpitaux de Paris, Hôpitaux Universitaires Paris-Sud, Le Kremlin-Bicêtre, Université Paris Sud, INSERM, Paris, France
Background/Purpose: Certolizumab pegol (CZP) is an anti-TNF drug approved for rheumatoid arthritis (RA), axial spondyloarthritis (axSpA), psoriatic arthritis (PsA), psoriasis (PSO) and Crohn’s disease (CD).…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].